NF-κB: Pivotal mediator or innocent bystander in atherogenesis?

Journal of Clinical Investigation

Volumn 107, Issue 3, 2001, Pages 255-264

  Collins, Tucker ^a   Cybulsky, Myron I ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; HOMOCYSTEINE; VASCULAR CELL ADHESION MOLECULE 1;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL DEATH; HEMODYNAMIC MONITORING; HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM; ANIMAL; AORTA; APOPTOSIS; ARTERIOSCLEROSIS; BIOSYNTHESIS; DIABETES MELLITUS; HEMODYNAMICS; HYPERTENSION; LEUKOCYTE; METABOLISM; MICROBIOLOGY; PATHOLOGY; PHYSIOLOGY; RISK FACTOR;

ANIMALS; AORTA; APOPTOSIS; ARTERIOSCLEROSIS; DIABETES COMPLICATIONS; ENDOTHELIUM, VASCULAR; HEMODYNAMIC PROCESSES; HOMOCYSTEINE; HUMANS; HYPERTENSION; LEUKOCYTES; NF-KAPPA B; OXIDATIVE STRESS; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0034746311     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI10373     Document Type: Review

References (47)

1. Atherosclerosis: An inflammatory disease
2. The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation
3. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion
4. Activated nuclear factor-kappaB is present in the coronary vasculature in experimental hypercholesterolemia
5. Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation
6. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis
7. Decreased lesion formation in CCR2-/-mice reveals a role for chemokines in the initiation of atherosclerosis
8. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice
9. Is NF-kappaB the sensor of oxidative stress?
10. Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein
11. Modified low-density lipoprotein and its constituents augment cytokine-activated vascular cell adhesion molecule-1 gene expression in human vascular endothelial cells
12. Lysophosphatidic acid activates nuclear factor kappa B and induces proinflammatory gene expression in endothelial cells
13. An animal model to study local oxidation of LDL and its biological effects in the arterial wall
14. Very low-density lipoprotein activates nuclear factor-kappaB in endothelial cells
15. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL
16. Peroxisome proliferator-activated receptor γ ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
17. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress
18. Angiotensin II induces interleukin-6 transcription in vascular smooth muscle cells through pleiotropic activation of nuclear factor-kappa B transcription factors
19. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: A potential link between the renin-angiotensin system and atherosclerosis
20. Activation of receptor for advanced glycation end products: A mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis
21. Leukocyte-endothelial interaction is augmented by high glucose concentrations and hyperglycemia in a NF-κB-dependent fashion
22. Homocysteine and atherothrombosis
23. Homocysteine-induced endoplasmic reticulum stress and growth arrest leads to specific changes in gene expression in human vascular endothelial cells
24. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1
25. Homocysteine provokes leukocyte-endothelium interaction by downregulation of nitric oxide
26. Roles of infectious agents in atherosclerosis and restenosis: An assessment of the evidence and need for future research
27. Role of reactive oxygen intermediates in cytomegalovitus gene expression and in the response of human smooth muscle cells to viral infection
28. Hostile takeovers: Viral appropriation of the NF-κB pathway
29. Cytomegalovirus-mediated modulation of adhesion molecule expression by human arterial and microvascular endothelial cells
30. Herpesvirus in atherosclerosis and thrombosis: Etiologic agents or ubiquitous bystanders?
31. Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression
32. The inhibition of endothelial activation by unsaturated fatty acids
33. Antioxidants and atherosclerotic heart disease
34. Alpha-Tocopheryl succinate inhibits moncytic cell adhesion to endothelial cells by suppressing NF-kappa B mobilization
35. 2-production in the pig coronary artery
36. IKKε is part of a novel PMA-inducible lκB kinase complex
37. Tyrosine phosphorylation of I kappa B-alpha activates NF-kappa B without proteolytic degradation of I kappa B-alpha
38. Crucial role of the amino-terminal tyrosine residue 42 and the carboxyl-terminal PEST domain of1kappaBalpha in NE-kappa B activation by an oxidative stress
39. NE-kappaB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and C-IAP2 to suppress caspase-8 activation
40. Induction of heine oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL
41. Expression of geme oxygenase-1 in atherosclerotic lesions
42. Vascular endothelium, hemodynamic forces, and atherogenesis
43. The NF-κB signal transduction pathway in aortic endothelial cells is primed for activation in regions predisposed to atherosclerotic lesion formation
44. Differential activation of NF-kappa B in human aortic endothelial cells conditioned to specific flow environments
45. Fluid shear stress activation of IkappaB kinase is integrin-dependent
46. Laminar shear stress inhibits vascular endothelial cell proliferation by inducing cyclin-dependent kinase inhibitor p21
47. Induction and stabilization ofI kappa B alpha by nitric oxide mediates inhibition of NF-kappa B